Bragar Eagel &amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Picard (PMI) To Contact Him Directly To Discuss Their Options  If you purchased or acquired Picard securities

Bragar Eagel & Squire, P.C. Urges Picard Medical, Inc. (NYSE:PMI) Investors to Contact the Firm Before April 3rd Regarding Their Rights

Class Action Lawsuit Filed Against Picard Medical, Inc. (PMI)

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>Bragar Eagel &amp;amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Picard (PMI) To Contact Him Directly To Discuss Their Options  If you purchased or acquired Picard securities</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>A class action lawsuit accuses Picard Medical (PMI) of misleading investors, particularly regarding insider trading. Following a significant stock price crash, the legal ramifications could further impact PMI&#039;s market sentiment and stock value.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>A class action lawsuit has been filed against Picard Medical, Inc. (PMI).</li><li>Investors claim PMI misled them regarding stock promotion schemes and insider trading.</li><li>PMI&#039;s stock price crashed 70% in October 2025 and continues to decline.</li><li>Investors can apply as lead plaintiffs until April 3, 2026.</li><li>Legal implications may weigh heavily on PMI’s stock performance.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Picard Medical, Inc. (PMI)</strong>: PMI faces a damaging class action lawsuit affecting its reputation and stock.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>This falls under &#039;Legal&#039; as it involves a shareholder lawsuit against PMI, which has potential implications for stock valuation and investor trust.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Legal proceedings can create negative sentiment, impacting PMI&#039;s stock price.</li><li>Continued stock price decline may lead to further investor sell-offs.</li><li>Settlement costs from the lawsuit could strain PMI’s financial resources.</li><li>Potential for additional lawsuits may exacerbate investor concerns.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Class action period for PMI shareholders is September 2 to October 31, 2025.</li><li>PMI&#039;s stock price fell from $3.99 to approximately $2.00.</li><li>Investors have until April 3, 2026, to apply for lead plaintiff status.</li><li>The lawsuit alleges misinformation and insider trading schemes affected stock valuation.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Consider shorting PMI as legal woes may depress the stock in the near term.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify"><strong>Bragar Eagel &amp; Squire, P.C. </strong><strong>Litigation Partner </strong><a href="https://www.globenewswire.com/Tracker?data=ZoFd6c9wNHlKm6BpPc026VEiCsroglkwo-eOzQpEx-KiNtTNUv8Fvke7sW-VVg5HjS1a7psHc0bu_6wBA36XG9m6LNzjL26gr6yeu4S3qmCikxLLI5mzZItHC_W2NFuZ" rel="nofollow" target="_blank"><strong>Brandon Walker</strong></a><strong> Encourages Investors Who Suffered Losses In Picard (PMI) To Contact Him Directly To Discuss Their Options</strong></p>  <p align="justify"><strong>If you purchased or acquired Picard securities between September 2, 2025, and October 31, 2025 and would like to discuss your legal rights, call Bragar Eagel &amp; Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.</strong></p>  <p align="justify">Click <a href="https://www.globenewswire.com/Tracker?data=V5fJWstldXorXP02LPsA5XvOj6PehnDgY5uvcl8-kkZi83acJsJ_6J2WiI0SmxZuBbGJAlhdBb6ZkmVNd8l2Kw==" rel="nofollow" target="_blank">here</a> to participate in the action.</p>  <p align="justify">NEW YORK, March  15, 2026  (GLOBE NEWSWIRE) -- </p>  <p align="justify"><strong>What's Happening:</strong></p>  <ul type="circle"><li style="margin-bottom:12pt; text-align:justify;"><a href="https://www.bespc.com" rel="nofollow" target="_blank">Bragar Eagel &amp; Squire, P.C</a>., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Picard Medical, Inc. ("Picard" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/PMI">PMI</a>) in the United States District Court for the Northern District of California San Jose Division on behalf of all persons and entities who purchased or otherwise acquired Picard securities between September 2, 2025, and October 31, 2025, both dates inclusive (the "Class Period").</li><li style="margin-bottom:12pt; text-align:justify;">Investors have until April 3, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.</li></ul>  <p align="justify"><strong>Allegation Details:</strong></p>  <ul type="circle"><li style="text-align:justify;">According to the complaint, defendants failed to disclose to investors: (1) that Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) that Picard's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.<br></br><br></br></li><li style="text-align:justify;">On October 24, 2025, Picard's stock price abruptly crashed 70%, to $3.99 per share. Since then, the Company's share price has continued to decline to approximately $2.00 per share.<br></br><br></br></li></ul>  <p align="justify"><strong>Next Steps:</strong></p>  <ul type="circle"><li style="text-align:justify;">If you purchased or otherwise acquired Picard shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact <a href="https://www.bespc.com/professionals/brandon-walker" rel="nofollow" target="_blank">Brandon Walker</a> or <a href="https://www.bespc.com/professionals/melissa-fortunato" rel="nofollow" target="_blank">Melissa Fortunato</a> by email at <a href="mailto:investigations@bespc.com" rel="nofollow" target="_blank">investigations@bespc.com</a>, telephone at (212) 355-4648, or by <a href="https://bespc.com/cases/PMI" rel="nofollow" target="_blank">filling out this contact form</a>. There is no cost or obligation to you.<br></br><br></br></li></ul>  <p><strong>About Bragar Eagel &amp; Squire, P.C.:</strong></p>  <p align="justify">Bragar Eagel &amp; Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities,<br></br>derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit <a href="https://www.globenewswire.com/Tracker?data=pgQICIao-uP4vQVihYfNkm99n_Oa8Diwa170yl2nQBaLHMVXBoP2QnJdw1uX6zIwa-D6oCOOXYxoDsnqEBHvjw==" rel="nofollow" target="_blank">www.bespc.com</a>.  Attorney advertising.  Prior results do not guarantee similar outcomes.<br></br>Follow us for updates on <a href="https://www.globenewswire.com/Tracker?data=w_R266F0UiXAKPP8K5zMzALesLn0a5N8GT32OxYG_n_ZgbFSAy7BwEXzy_HMyVPOZU43Wt94HcUjNPj3U3vNt-mgOkG4LTuSmgRKpF8i2kW8SyVC8qIjs_EIayOCoeIC" rel="nofollow" target="_blank">LinkedIn</a> and <a href="https://www.globenewswire.com/Tracker?data=71okG9qxKvt_Yx0s6fSLSLf5FvNqDQobPJzOd9wT2efwJsCMxnBYLW_uGsus23rGqrME2q4rB_0A_COiJor6Sep3zOR1kOtheBvRrS7qNHDt9so1m0lnbgWfaePIaxPp" rel="nofollow" target="_blank">Facebook</a>, and keep up with other news by following Brandon Walker, Esq. on <a href="https://www.globenewswire.com/Tracker?data=w_R266F0UiXAKPP8K5zMzLCQNhKkJ34ruc0aOlCBCxuMJFmCn9ugXRmVqfU-DJlsv32FdUu61MeUgnyiwmR-Sw1UADp_lh7BoPeyYJFy13NRAFLIIw8g6LmXtneiYBCR" rel="nofollow" target="_blank">LinkedIn</a>.</p>  <p><strong>Contact Information:</strong></p>  <p>Bragar Eagel &amp; Squire, P.C.<br></br>Brandon Walker, Esq.<br></br>Melissa Fortunato, Esq.<br></br>(212) 355-4648<br></br><a href="https://www.globenewswire.com/Tracker?data=eUKZoYiGAkfw7YNwGP0u9EtCIeT66dGYCA7eeVA4V9a9e0ZXxusZMr3j5q8LkqESjav1Gv5OwBojputk2sRfqm7pHYh5PfmEGjY3NGPv7u-ocwytHtWnZS6j08s0HdWK" rel="nofollow" target="_blank"><u>investigations@bespc.com</u></a><br></br><a href="https://www.globenewswire.com/Tracker?data=pgQICIao-uP4vQVihYfNkpW_YPAW8lnVlIzoxrSyp_KxOsVl63IUg6K0uJks9GafOUB2KYh3HklYGe6agRTDJw==" rel="nofollow" target="_blank"><u>www.bespc.com</u></a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTY3MTk0OCM3NDg1MTM3IzIxMDAzOTg="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/YzMzMTI3NDItYzBjOC00ODYwLTk1NjgtOWVhZjA4NjQ0YTk3LTExMTE5NjktMjAyNi0wMy0xNS1lbg==/tiny/Bragar-Eagel-Squire.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/29481954-f2ff-4756-b5a9-d982a6497bd0"><img src="https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg" border="0" width="150" height="75" alt="Primary Logo"></img></a></p>

A class action lawsuit accuses Picard Medical (PMI) of misleading investors, particularly regarding insider trading. Following a significant stock price crash, the legal ramifications could further impact PMI's market sentiment and stock value.

Bragar Eagel & Squire, P.C. Urges Picard Medical, Inc. (NYSE:PMI) Investors to Contact the Firm Before April 3rd Regarding Their Rights

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News